Skip to main content
Eleanor J. Barnes on Muck Rack

Eleanor J. Barnes

As seen in: Color Research & Application, Nature, Wiley Online Library, PLOS, BMJ Open, Medscape, Science Magazine, BioRxiv, The Lancet, Canadian Journal of Infectious Diseases & Medical Microbiology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eleanor J.

Contact Eleanor J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Response to Comments on ‘Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines’

|
By Cori Campbell, Tingyan Wang, Eleanor J. Barnes, Philippa Matthews
| Wiley Online Library Verified
Dear Editor, Thank you for the opportunity to respond to the letter from Katkuri et al. [1]. We thank this group for providing positive feedback on our report of treatment eligibility for adults living with Hepatitis B virus (HBV) infection in the UK [2], which was undertaken by the Health Informatics Collaborative (HIC) for viral hepatitis and liver disease [3]. First, we address the feedback about the HIC approach of using a single positive HBV test as a marker of chronic infection.
Open in Who Shared Issue with article?

HCV response-guided therapy: is shorter always better? - Authors' reply

|
By Graham Cooke Verified, Sarah Walker, Eleanor J. Barnes
| The Lancet Verified
We thank Lei Xu and Wenzhe Zhao for their interesting observations focused on response-guided therapy in the era of direct-acting antivirals. We support their view that strategies proposed to date to select those patients with hepatitis C infection who could be cured with 4 weeks (ultra-short) treatment are still not able to offer high enough cure rates to be recommended routinely.
Open in Who Shared Issue with article?

Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1

|
By Maria Fransiska Pudjohartono, Kate Powell, Peter Medawar Building, Eleanor J. Barnes, PLOS Pathogens
| PLOS
Loading metrics Open Access Peer-reviewed Research Article ? This is an uncorrected proof. Citation: Pudjohartono MF, Powell K, Barnes E, Klenerman P, Provine NM (2025) Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1. PLoS Pathog 21(8): e1013432.
Open in Who Shared Issue with article?
See all 20 licensed articles (22 Total)